CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 101 filers reported holding CYTOKINETICS INC in Q4 2016. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2017 | $289,000 | -46.1% | 23,884 | -42.8% | 0.01% | -50.0% |
Q1 2017 | $536,000 | +102.3% | 41,748 | +91.5% | 0.03% | +23.8% |
Q4 2016 | $265,000 | +231.2% | 21,800 | +83.4% | 0.02% | +425.0% |
Q2 2015 | $80,000 | -25.9% | 11,888 | -25.3% | 0.00% | -42.9% |
Q1 2015 | $108,000 | -31.6% | 15,912 | -4.2% | 0.01% | -75.0% |
Q1 2014 | $158,000 | +11.3% | 16,615 | +35.6% | 0.03% | +33.3% |
Q2 2013 | $142,000 | – | 12,249 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |